Changing a specific part of the Cav3.1 protein prevents it from sending signals that tell the body it is full after eating protein.
See the scientific wording
Mutation of the leucine-binding site on the Cav3.1 protein abolishes the protein's capacity to mediate satiety signals triggered by dietary protein intake.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Case-Control StudyAnimal2026
Scientists found that if you break the part of the Cav3.1 protein that grabs leucine (a building block of protein), the brain can’t tell when you’ve eaten enough protein — so you keep eating. This proves that part is essential for feeling full after protein.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When dietary protein breaks down into leucine, leucine binds to a specific site on the Cav3.1 protein in brain cells that control fullness. This binding makes the Cav3.1 channel open more easily, letting calcium flow into the cells. The calcium surge activates these cells, which send signals to stop eating and reduce food intake.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Changing a specific part of the Cav3.1 protein prevents it from sending signals that tell the body it is full after eating protein.
Mechanism
1 studyLeucine from protein binds to Cav3.1 in brain cells that control fullness, making them more likely to activate. This triggers a calcium signal that tells the brain to stop eating. Without this binding site, the brain cannot detect protein intake and does not signal fullness.
When dietary protein breaks down into leucine, leucine binds to a specific site on the Cav3.1 protein in brain cells that control fullness. This binding makes the Cav3.1 channel open more easily, letting calcium flow into the cells. The calcium surge activates these cells, which send signals to stop eating and reduce food intake.
Leucine from dietary protein binds to a hydrophobic pocket in the Cav3.1 voltage-gated calcium channel
Leucine binding lowers the voltage threshold required for Cav3.1 channel opening
Cav3.1 channel opening permits calcium influx into hypothalamic POMC neurons
Calcium influx activates POMC neurons, triggering downstream anorectic signaling pathways
Activated POMC neurons suppress appetite and reduce food intake
Evidence from Studies
Supporting (1)
Community contributions welcome
Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary protein
Scientists found that if you break the part of the Cav3.1 protein that grabs leucine (a building block of protein), the brain can’t tell when you’ve eaten enough protein — so you keep eating. This proves that part is essential for feeling full after protein.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Genetic Mutations in Cav3.1 and Satiety Signaling Across Dietary Protein Interventions
Systematic review and meta-analysis of all published studies examining Cav3.1 leucine-binding site mutations, dietary protein exposure, and satiety signal output in animal or in vitro models.
Controlled Genetic Knock-in vs Wild-type Cav3.1 in Mice: Satiety Response to Protein Meals
Randomized controlled trial in genetically modified mice with Cav3.1 leucine-binding site mutation versus wild-type controls, measuring satiety signals (e.g., hypothalamic activation, feeding behavior) after standardized protein meals over 7 days.
Longitudinal Cohort of Individuals with Naturally Occurring Cav3.1 Mutations and Dietary Protein Intake Patterns
Prospective cohort study following humans with confirmed Cav3.1 leucine-binding site mutations and matched controls, measuring satiety hormone levels, meal frequency, and caloric intake over 12 months during controlled protein diets.
Electrophysiological Response of Cav3.1 Mutant vs Wild-type Channels to Leucine in HEK293 Cells
In vitro patch-clamp experiments comparing leucine-induced Cav3.1 channel activity in HEK293 cells expressing wild-type versus leucine-binding site mutant Cav3.1 proteins.
Behavioral and Neurochemical Analysis of Cav3.1 Leucine-Binding Site Mutant Mice During Protein Feeding
Animal study in transgenic mice with Cav3.1 leucine-binding site mutation, measuring food intake, hypothalamic c-Fos expression, and plasma satiety hormones after controlled protein meals over 14 days.
